The potential use of prostasin as a marker of ovarian cancer has been suggested in a study by Mok et al. [64] that demonstrated 120- to 410-fold higher prostasin mRNA expression in ovarian cancer cell lines than normal ovarian cell lines. This evidence concerns the gene PRSS8 and ovarian carcinoma.